General Information of This Drug (ID: DMDL27I)

Drug Name
Oxytocin   DMDL27I
Synonyms
OXYTOCIN; Pitocin; 50-56-6; Ocytocin; Endopituitrina; Orasthin; Syntocinon; Oxytocine; Oxitocina; Oxytocinum; (1-Hemicystine)oxytocin; Piton S; Oxytocic hormone; UNII-1JQS135EYN; 3-Isoleucine-8-leucine vasopressin; Partocon; Oxystin; alpha-Hypophamine; Synthetic oxytocin; 1JQS135EYN; Ocytocinum; Syntocinone; Utedrin; Oxtocin; Uteracon; Syntocin; Synpitan; Presoxin; Di-sipidin; CHEMBL395429; CHEBI:7872; Nobitocin S; Atonin O; Oxetakain [Czech]; Ossitocina [DCIT]; Oxytocine [INN-French]; Oxytocinum [INN-Latin]; Oxitocina [INN-Spanish]; Posterior; Oxytocin (intranasal/ muco system, autism); [3H]OT (human, mouse, rat)
Indication
Disease Entry ICD 11 Status REF
Autism spectrum disorder 6A02 Approved [1]
Ductal breast carcinoma in situ N.A. Approved [2]
Postpartum haemorrhage JA43 Approved [2]
Lactation failure JB46.3 Phase 3 [3]
Coronavirus Disease 2019 (COVID-19) 1D6Y Phase 2 [4]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

16 Clinical Trial Drug Combination(s) Consisting of This drug
DrugCom Name DrugCom ID Component Drug Indication REF
Ergonovine + Oxytocin DCXKHL5 Ergonovine Postpartum Hemorrhage [5]
Ergonovine + Oxytocin DC8MZXF Ergonovine Cesarean Section Complications [6]
Misoprostol + Oxytocin DCLS851 Misoprostol Vaginal Delivery [7]
Oxytocin + Oxytocin DC2D81A Oxytocin Postpartum Hemorrhage [5]
Oxytocin + Carboprost tromethamine DC30LCB Carboprost tromethamine Postpartum Hemorrhage [5]
Oxytocin + Carbetocin DCSPUVW Carbetocin Postpartum Hemorrhage [5]
Oxytocin + Carbetocin DC0F4ZF Carbetocin Postpartum Hemorrhage [8]
Oxytocin + Carboprost tromethamine DC3O1YE Carboprost tromethamine Postpartum Hemorrhage [9]
Oxytocin + Magnesium Sulfate DCB1LU4 Magnesium Sulfate Postpartum Hemorrhage [10]
Oxytocin + Phenylephrine DCBP3YY Phenylephrine Postpartum Hemorrhage [11]
Oxytocin + Norepinephrine DCN6TM6 Norepinephrine Postpartum Hemorrhage [11]
Oxytocin + Etomidate DCULI8G Etomidate Postpartum Hemorrhage [12]
Oxytocin + Propofol DCYF1PZ Propofol Postpartum Hemorrhage [12]
Propranolol + Oxytocin DCH6BK8 Propranolol Postpartum Hemorrhage [13]
Propranolol + Oxytocin DCRWUJM Propranolol Poor; Labor [14]
Oxytocin + Carbetocin DC0ABT2 Carbetocin CARBETOCIN FOR PREVENTION OF PLACENTAL RETAINED [15]
------------------------------------------------------------------------------------
⏷ Show the Full List of 16 DrugCom(s)

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2174).
2 Oxytocin FDA Label
3 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800039450)
4 Phase II RCT to Assess Efficacy of Intravenous Administration of Oxytocin in Patients Affected by COVID-19 (OsCOVID19)
5 ClinicalTrials.gov (NCT06285409) Comparing the Dose-response Profiles of Uterotonics After Initial Carbetocin Administration - an Ex-vivo Study in Desensitized Human Myometrium
6 ClinicalTrials.gov (NCT03578263) Carbetocin Versus Oxytocin and Ergometrine for the Prevention of Postpartum Hemorrhage
7 ClinicalTrials.gov (NCT04004845) Labor Protocol Study
8 ClinicalTrials.gov (NCT01689298) Carbetocin vs. Oxytocin: In-vitro Myometrial Contractions With and Without Oxytocin Pre-treatment
9 ClinicalTrials.gov (NCT01869556) Comparison of IV Ergonovine With IM Carboprost, With Oxytocin IV, During Cesarean Section for Failure to Progress
10 ClinicalTrials.gov (NCT02647268) Effect of Magnesium Sulphate Pre-exposure on Oxytocin-induced Contractility in Desensitized Human Myometrium - an in Vitro Study
11 ClinicalTrials.gov (NCT06285396) Effect of Ephedrine, Phenylepinephrine, and Norepinephrine on Myometrial Contractility in Pregnant People With Type II and Gestational Diabetes During Cesarean Section: An In-vitro Study
12 ClinicalTrials.gov (NCT03852797) Spontaneous and Oxytocin-induced Contractility After Exposure to Intravenous Anesthetic Agents: an In-vitro Study in Human Myometrium
13 ClinicalTrials.gov (NCT03434444) In Vitro Optimization of Oxytocin-induced Myometrial Contractility by Propranolol
14 ClinicalTrials.gov (NCT02702674) The Effect of Coadministration of Oral Propranolol to Oxytocin on Induction of Labor
15 ClinicalTrials.gov (NCT01827124) Randomized Clinical Trial for Comparison Of Intravenous Carbeitocin Versus Oxytocin In Management Of Placental Delivery In Second Trimester Interruption